Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts


Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Menu Search
The Sidney Kimmel Comprehensive Cancer Center

In This Section      

Melanoma and Other Skin Cancers

If you’ve received a melanoma diagnosis or a suspicious biopsy result, The Johns Hopkins Melanoma Program is here to help. Our program brings together industry-leading care and world-class research. Our multidisciplinary group of renowned experts works as a team to determine individualized treatment plans and clinical trials that will benefit our patients most.

about us

About Us

Learn more about the Johns Hopkins Melanoma Program and our team of melanoma specialists.



Meet with a Hopkins melanoma expert at one of our convenient locations. 

Kimmel Cancer Center in DC

Kimmel Cancer Center in DC

Learn more about our melanoma program in the Washington, DC area.

Suzanne Topalian, MD

Dr. Suzanne Topalian honored with AAMC award

Suzanne Topalian, M.D., was recently bestowed the 2021 Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC). Read more or listen to Dr. Topalian's interview.


Cutting Edge Research


Janis Taube, MD, MsC, explains how AstroPath, a platform that she developed with Alex Szalay, PhD, of Johns Hopkins University pairs astronomy with pathology to identify predictive biomarkers for cancer immunotherapy.


Patients of The Johns Hopkins Melanoma Program have access to revolutionary clinical trials, as Hopkins Melanoma researchers are constantly exploring new therapy targets. Hopkins was among the first to pioneer the investigation of immune-based therapies involving PD-1, a protein whose pathway can be blocked to restore the body’s ability to detect and attack cancer. Our clinical research programs offer studies for patients with various stages of melanoma, ranging from preventing disease recurrence in high-risk surgical patients to developing innovative drug therapies for patients with advanced metastatic disease.


The Johns Hopkins Melanoma Program treats patients at:

For more information, please contact Melanoma Program Coordinator Kim Palmer at (410) 616-7660.